Evolus, Inc. (EOLS)
5.65
-0.09
(-1.57%)
USD |
NASDAQ |
Jan 09, 16:00
5.75
+0.10
(+1.77%)
Pre-Market: 20:00
Evolus EPS Diluted (Quarterly): -0.2431 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ICU Medical, Inc. | -0.1376 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.74M |
| Revenue (Quarterly) | 68.97M |
| Total Expenses (Quarterly) | 84.70M |
| Enterprise Value | 477.60M |
| Gross Profit Margin (Quarterly) | 64.81% |
| Profit Margin (Quarterly) | -22.82% |
| Earnings Yield | -16.15% |
| Normalized Earnings Yield | -15.92 |